Johnson and Johnson will spend USD 16.6 billion to purchase cardiovascular know-how firm Abiomed to strengthen its medical machine division.

The well being care large mentioned on Tuesday that it’s going to pay USD 380 for every Biomed share and likewise present one other USD 35 per share in money if some business and scientific milestones are met.

Abiomed develops know-how that treats coronary artery illness and coronary heart failure.

(This story has not been edited by Devdiscourse employees and is auto-generated from a syndicated feed.)